Výsledky vyhledávání - "G J, Weverling"

Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?

Publikováno v: Scopus-Elsevier
AIDS (London, England), 19(16), 1865-1875. Lippincott Williams and Wilkins

There are positive reports about the ability of antiretroviral agents to prevent mother-to-child transmission (MTCT) of HIV. The authors undertook a pooled analysis of African breast-feeding mothers from clinical trials of various antiretroviral regi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3016cd3c49dabf215344ecccaa52a301
https://doi.org/10.1097/01.aids.0000188423.02786.55

Zobrazit plný text záznamu

AIDS vaccines that allow HIV-1 to infect and escape immunologic control - A mathematic analysis of mass vaccination

Autor: Jaap Goudsmit, G. J. Weverling, Marijn van Ballegooijen, Johannes A. Bogaards, Maarten C. Boerlijst

Publikováno v: Journal of acquired immune deficiency syndromes (1999), 34(2), 214-220. Lippincott Williams and Wilkins
Bogaards, J A, Van Ballegooijen, M, Weverling, G J, Boerlijst, M C & Goudsmit, J 2003, ' AIDS vaccines that allow HIV-1 to infect and escape immunologic control : A mathematic analysis of mass vaccination ', Journal of Acquired Immune Deficiency Syndromes, vol. 34, no. 2, pp. 214-220 . https://doi.org/10.1097/00126334-200310010-00012
Journal of Acquired Immune Deficiency Syndromes, 34(2), 214-220

Cytotoxic T lymphocyte (CTL)-based HIV vaccine concepts shown to reduce viremia and postpone disease but not to prevent infection in monkeys are currently in human phase 1 trials. To evaluate the potential efficacy of vaccines that cannot prevent HIV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7e5c61cac2f4a81c61ab2bfb9aad0e4
https://doi.org/10.1097/00126334-200310010-00012

Zobrazit plný text záznamu

Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA Cohort

Autor: Frank de Wolf, Jeanne P. Dieleman, Inge C. Gyssens, Kees Brinkman, Peter Reiss, Bruno H. Stricker, Joep M. A. Lange, G. J. Weverling, Wilhelmina M. C. Mulder, Miriam C. J. M. Sturkenboom, Marielle Jambroes

Publikováno v: AIDS (London, England), 16(5), 737-745. Lippincott Williams and Wilkins
AIDS, 16, 737-745. Lippincott Williams & Wilkins

Background: Toxicity is the most important reason for premature switching of highly active antiretroviral therapy (HAART). In order to optimize the benefit-risk ratio of HAART, guidelines for toxicity management are needed. Objective: An observationa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed2a90e94ffc31f67195b58b91bd5da1
https://doi.org/10.1097/00002030-200203290-00009

Zobrazit plný text záznamu

Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains

Autor: Jaap Goudsmit, Maarten C. Boerlijst, J. M. A. Lange, Frank Miedema, L. van der Hoek, R. A. Coutinho, G. J. Weverling, A. de Ronde

Publikováno v: AIDS (London, England), 15(17), 2293-2301. Lippincott Williams and Wilkins

Objective: Because maintenance of treatment success in HIV-1 infection requires viruses to remain therapy sensitive in drug-naive seropositive persons, we looked at the primary infections caused by drug-resistant HIV-1 over time. Furthermore, to stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3270c5edb505b5377efe636cb1f16269
https://doi.org/10.1097/00002030-200111230-00011

Zobrazit plný text záznamu

Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection

Autor: Ferdinand W. N. M. Wit, Elisabeth H. Gisolf, A. Japour, G. J. Weverling, Peter Reiss, M. van der Valk, S. A. Danner

Publikováno v: AIDS, 15(7), 847-855. Lippincott Williams and Wilkins
AIDS (London, England), 15(7), 847-855. Lippincott Williams and Wilkins
Van Der Valk, M, Gisolf, E H, Reiss, P, Wit, F W N M, Japour, A, Weverling, G J & Danner, S A 2001, ' Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection ', AIDS, vol. 15, no. 7, pp. 847-855 . https://doi.org/10.1097/00002030-200105040-00005

Background: Changes in body fat distribution are an adverse effect of therapy with HIV protease inhibitors (PI). It has been suggested that nucleoside analogue reverse transcriptase inhibitors (NRTI) may also contribute to this so-called lipodystroph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ce311c0eed3cc5023f80753365eb751
https://doi.org/10.1097/00002030-200105040-00005

Zobrazit plný text záznamu

A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients

Autor: Kiat Ruxrungtham, J. M. A. Lange, Eugene Kroon, Chaiwat Ungsedhapand, R. Van Leeuwen, G. J. Weverling, Supranee Buranapraditkun, Somsong Teeratakulpisarn, Praphan Phanuphak, David A. Cooper, Sasiwimol Ubolyam, Chaiyos Kunanusont

Publikováno v: AIDS (London, England), 14(10), 1375-1382. Lippincott Williams and Wilkins

To evaluate the safety and efficacy of four different regimens of didanosine (ddI) + stavudine (d4T) in HIV-infected Thais. Prospective, open-label, randomized study. Patients were randomized to four regimens of high and low doses of ddI and d4T or t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9be7b7ec2b484cc19f5b3f86a97fefb9
https://doi.org/10.1097/00002030-200007070-00010

Zobrazit plný text záznamu

Risk Factors for Human Herpesvirus 8 Seropositivity and Seroconversion in a Cohort of Homosexula Men

Autor: Nicole H. T. M. Dukers, Thomas F. Schulz, Roel A. Coutinho, Maria Prins, Ronald B. Geskus, Neil Renwick, Jaap Goudsmit, G. J. Weverling

Publikováno v: American Journal of Epidemiology. 151:213-224

Sexual and nonsexual modes of transmission of human herpesvirus 8 (HHV8) have been suggested, but specific routes remain unclear. Therefore, the objective of this study was to assess risk factors for HHV8 seropositivity and determine specific sexual

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f693b0332dbdc04824ad1ae2b2bcced2
https://doi.org/10.1093/oxfordjournals.aje.a010195

Zobrazit plný text záznamu

Short Communication: Cellular Proviral HIV Type 1 DNA Load Persists after Long-Term RT-Inhibitor Therapy in HIV Type 1 Infected Persons

Autor: Peter Reiss, G. J. Weverling, Sylvia M. Bruisten, Charles A. Boucher, J. G. Huisman, A. E. Loeliger, P. Van Swieten, Rob Schuurman

Publikováno v: AIDS Research and Human Retroviruses. 14:1053-1058

In a set of 42 antiretroviral naive HIV-1 infected persons who were treated with either Zidovudine (AZT) monotherapy, or a combination of AZT + ddC (Zalcitabine) or AZT + ddl (Didanosine),...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::79cf6d046b597571f6787e787b5eb1c9
https://doi.org/10.1089/aid.1998.14.1053

Zobrazit plný text záznamu

The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy

Autor: F. De Wolf, G. J. Weverling, R. M. W. Hoetelmans, R. W. ten Kate, J. W. Mulder, Jos H. Beijnen, H. M. Weigel, P. H. J. Frissen, Marijke T. L. Roos, J. M. A. Lange, Hanneke Schuitemaker, Suzanne Jurriaans, M. H. E. Reijers, Ferdinand W. N. M. Wit

Publikováno v: AIDS (London, England), 12(11), F111-F115. Lippincott Williams and Wilkins

Objective: To investigate the relationship between exposure to antiretroviral drugs and the initial decline of plasma HIV-1 RNA. Design: Open-label study in antiretroviral-naive HIV-1 infected patients using a quadruple drug regimen [nelfinavir (NFV)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2028bf69810bd6f6bccacd6894eeac5c
https://doi.org/10.1097/00002030-199811000-00002

Zobrazit plný text záznamu

Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy

Autor: F. De Wolf, R. Van Leeuwen, N.A. Foudraine, Pieter L. Meenhorst, G. J. Weverling, Peter Reiss, Marijke T. L. Roos, Peter P. Koopmans, T. van Gool, Joep M. A. Lange, P.J.J.A. van den Broek

Publikováno v: AIDS (London, England), 12(1), 35-41. Lippincott Williams and Wilkins
Aids, 12, 35-41
Aids, 12, pp. 35-41

BACKGROUND: A substantial number of patients with advanced HIV infection suffer from intractable diarrhoea. The aim of this study was to evaluate whether potent antiretroviral therapy could alleviate such diarrhoea. METHODS: In an open randomized stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a4e9d7eb278c0cd30d083434568d2e7
https://doi.org/10.1097/00002030-199801000-00005

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání